Does 17-alpha hydroxyprogesterone caproate prevent recurrent preterm birth in obese women?

American Journal of Obstetrics and Gynecology

Volumn 213, Issue 6, 2015, Pages 844.e1-844.e6

  Heyborne, Kent D ^a,b   Allshouse, Amanda A ^c   Carey, J Christopher ^a,b  

^a DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Global Health and Health Disparities   (United States)

Author keywords

17 alpha hydroxyprogesterone caproate; body mass index; obesity; prematurity; preterm birth; progesterone

Indexed keywords

GESTONORONE CAPROATE; PLACEBO; 17-ALPHA-HYDROXY-PROGESTERONE CAPROATE; PROGESTERONE DERIVATIVE;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OBESITY; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TREATMENT OUTCOME; CLINICAL TRIAL; COMPLICATION; GESTATIONAL AGE; PREGNANCY; PREMATURE BIRTH;

ADULT; BODY MASS INDEX; FEMALE; GESTATIONAL AGE; HUMANS; HYDROXYPROGESTERONES; OBESITY; PREGNANCY; PREMATURE BIRTH; PROGESTERONE CONGENERS; RECURRENCE;

EID: 84979859136     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2015.08.014     Document Type: Article

References (10)

1. C. Crump, K. Sundquist, J. Sundquist, and M.A. Winkleby Gestational age at birth and mortality in young adulthood JAMA 306 2011 1233 1240
2. D. Moster, R.T. Lie, and T. Markestad Long-term medical and social consequences of preterm birth N Engl J Med 359 2008 262 273
3. EXPRESS Group V. Fellman, L. Hellström-Westas, M. Norman, and et al. One-year survival of extremely preterm infants after active perinatal care in Sweden JAMA 301 2009 2225 2233
4. M.C. McCormick, J.S. Litt, V.C. Smith, and J.A. Zupancic Prematurity: an overview and public health implications Annu Rev Public Health 32 2011 367 379
5. P.J. Meis, M. Klebanoff, E. Thom, and et al. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate N Engl J Med 348 2003 2379 2385
6. S.N. Caritis, R. Venkataramanan, and E. Thom Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network and Obstetric-Fetal Pharmacology Research Units Network. Relationship between 17-alpha hydroxyprogesterone caproate concentration and spontaneous preterm birth Am J Obstet Gynecol 210 2014 128.e1 128.e6
7. S.N. Caritis, S. Sharma, and R. Venkataramanan Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Pharmacokinetics of 17-hydroxyprogesterone caproate in multifetal gestation Am J Obstet Gynecol 205 2011 40.e1 40.e8
8. K.M. Flegal, M.D. Carroll, C.L. Ogden, and L.R. Curtin Prevalence and trends in obesity among US adults, 1999-2008 JAMA 303 2010 235 241
9. Committee on Practice Bulletins-Obstetrics, American College of Obstetricians and Gynecologists Prediction and prevention of preterm birth. Practice bulletin no. 130 Obstet Gynecol 120 2012 964 973
10. Society for Maternal-Fetal Medicine Publications Committee, with assistance of Vincenzo Berghella Progesterone and preterm birth prevention: translating clinical trials data into clinical practice Am J Obstet Gynecol 206 2012 376 386